e-learning
resources
Munich 2014
Monday, 08.09.2014
Animal models in respiratory drug development
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Both intranasal and intraperitoneal administration of human tubal mesenchymal stem cells (htMSC) ameliorates experimental COPD model
J. P. Peron, G. Moraes, A. Brito, E. Silveira, B. Rodrigues Jr., R. Avelino, B. Franco, G. Rossi, M. Pellaty, M. Zats, L. Evangelista, S. Halpern, R. Vieira, A. P. Oliveira (São Paulo, Brazil)
Source:
International Congress 2014 – Animal models in respiratory drug development
Session:
Animal models in respiratory drug development
Session type:
Poster Discussion
Number:
1792
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. P. Peron, G. Moraes, A. Brito, E. Silveira, B. Rodrigues Jr., R. Avelino, B. Franco, G. Rossi, M. Pellaty, M. Zats, L. Evangelista, S. Halpern, R. Vieira, A. P. Oliveira (São Paulo, Brazil). Both intranasal and intraperitoneal administration of human tubal mesenchymal stem cells (htMSC) ameliorates experimental COPD model. Eur Respir J 2014; 44: Suppl. 58, 1792
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Synergistic effect of human tubal mesenchymal stem cell (htMSCs) and low level laser (LLL) therapy significantly reduces experimental COPD in mice
Source: International Congress 2014 – Animal models in respiratory drug development
Year: 2014
Exogenous administration of bone marrow-derived stem cells in experimental COPD
Source: Annual Congress 2013 –Cutting edge: drug delivery to the airways
Year: 2013
Pretreatment of human adipose derived mesenchymal stem cells with PPAR-γ agonist improved effects of regeneration in elastase induced emphysema mouse model
Source: International Congress 2015 – Cellular and molecular mechanisms of COPD and emphysema
Year: 2015
Effects of autologous mesenchymal stromal cell treatment for severe emphysema on lung tissue: A clinical trial
Source: International Congress 2015 – The multiple facets of stem and progenitor cells in lung health and disease
Year: 2015
Effect of low level laser (LLL) and mesenchymal stem cells (htMSCs) therapies on cigarette-induced lung inflammation in mice
Source: Annual Congress 2013 –Tobacco use in different countries: crisis to disease
Year: 2013
Intratracheal administration of bone marrow-derived mesenchymal stem cells ameliorates lung function
Source: International Congress 2016 – Therapeutic horizons: novel targets and pharmacological models
Year: 2016
Cell therapy by adipose stromal cells affect tracheal responsiveness and inflammatory responses in guinea pigs model of COPD
Source: International Congress 2015 – New models for treating airway diseases
Year: 2015
Development of a human COPD model-on-a-chip to mimic disease exacerbation (a small airway-on-a-chip model)
Source: International Congress 2014 – Novel approaches and evidence for drug development in respiratory diseases
Year: 2014
Adipose derived stem cells ameliorate airway inflammation in mouse models of asthma
Source: International Congress 2015 – Asthma and lung immunology
Year: 2015
Comparative effects of inhaled and intravenous mesenchymal stem cells in bleomycin-induced pulmonary fibrosis in rabbits
Source: Annual Congress 2013 –Cutting edge: drug delivery to the airways
Year: 2013
Effect of roflumilast on airway remodeling in a murine model of chronic asthma
Source: International Congress 2015 – New models for treating airway diseases
Year: 2015
Repeated lipopolysaccharide stimulation causes corticosteroid insensitive inflammation in lung via phosphoinositide-3-kinase δ signaling
Source: International Congress 2014 – New treatments for cough, asthma, COPD and ILDs
Year: 2014
Targeted lung denervation in the healthy sheep model - A potential treatment for COPD
Source: International Congress 2014 – Rationale behind respiratory drug development
Year: 2014
Inhaled corticosteroids (ICS) attenuates epithelial mesenchymal transition (EMT) in COPD: A key to understanding long term benefits?
Source: Annual Congress 2012 - Basic and translational studies in COPD
Year: 2012
Effect of simvastatin on steroid-resistence in human epithelial cultured cells: A preliminary study
Source: International Congress 2015 – New models for treating airway diseases
Year: 2015
Anti-inflammatory effects of the novel phosphodiesterase type 4 inhibitor CHF6001 on COPD alveolar macrophages and lung tissue
Source: International Congress 2014 – Novel targets and drugs for asthma and COPD
Year: 2014
Effect of mast cells degranulation blockade on the inflammatory response outcome in the COPD model
Source: International Congress 2016 – New signalling pathways in COPD
Year: 2016
Combining an epithelial repair factor and anti-fibrotic with a corticosteroid offers optimal treatment for the pathogenesis of allergic airways disease
Source: International Congress 2016 – Novel mechanisms and treatment modalities in asthma
Year: 2016
COPD airway epithelium secretion attracts and activates neutrophils
Source: International Congress 2014 – Novel evidence relating to respiratory treatment development
Year: 2014
Cellular approach of salbutamol effects on chronic lung inflammation induced by OVA in murine model
Source: Eur Respir J 2004; 24: Suppl. 48, 127s
Year: 2004
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept